222 related articles for article (PubMed ID: 25030115)
1. Impact of solidification on the performance of lipid-based colloidal carriers: oil-based versus self-emulsifying systems.
Alinaghi A; Tan A; Rao S; Prestidge CA
Curr Drug Deliv; 2015; 12(1):16-25. PubMed ID: 25030115
[TBL] [Abstract][Full Text] [Related]
2. Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro.
Dening TJ; Rao S; Thomas N; Prestidge CA
Eur J Pharm Biopharm; 2016 Apr; 101():33-42. PubMed ID: 26812284
[TBL] [Abstract][Full Text] [Related]
3. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
[TBL] [Abstract][Full Text] [Related]
4. Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.
Cuiné JF; Charman WN; Pouton CW; Edwards GA; Porter CJ
Pharm Res; 2007 Apr; 24(4):748-57. PubMed ID: 17372700
[TBL] [Abstract][Full Text] [Related]
5. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.
Mohsin K
AAPS PharmSciTech; 2012 Jun; 13(2):637-46. PubMed ID: 22547370
[TBL] [Abstract][Full Text] [Related]
6. Quality-by-design based development of a self-microemulsifying drug delivery system to reduce the effect of food on Nelfinavir mesylate.
Kamboj S; Rana V
Int J Pharm; 2016 Mar; 501(1-2):311-25. PubMed ID: 26854426
[TBL] [Abstract][Full Text] [Related]
7. Optimized formulation of solid self-microemulsifying sirolimus delivery systems.
Cho W; Kim MS; Kim JS; Park J; Park HJ; Cha KH; Park JS; Hwang SJ
Int J Nanomedicine; 2013; 8():1673-82. PubMed ID: 23641156
[TBL] [Abstract][Full Text] [Related]
8. Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity.
Ishak RA; Osman R
Int J Pharm; 2015 May; 485(1-2):249-60. PubMed ID: 25772421
[TBL] [Abstract][Full Text] [Related]
9. Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.
Christophersen PC; Christiansen ML; Holm R; Kristensen J; Jacobsen J; Abrahamsson B; Müllertz A
Eur J Pharm Sci; 2014 Jun; 57():232-9. PubMed ID: 24056027
[TBL] [Abstract][Full Text] [Related]
10. Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility.
Bolko K; Zvonar A; Gašperlin M
Drug Dev Ind Pharm; 2014 Jan; 40(1):102-9. PubMed ID: 23301796
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.
Nekkanti V; Rueda J; Wang Z; Betageri GV
Int J Pharm; 2016 May; 505(1-2):79-88. PubMed ID: 27041124
[TBL] [Abstract][Full Text] [Related]
12. Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs.
Vithani K; Jannin V; Pouton CW; Boyd BJ
Adv Drug Deliv Rev; 2019 Mar; 142():16-34. PubMed ID: 30677448
[TBL] [Abstract][Full Text] [Related]
13. Nanocrystal-silica-lipid hybrid particles for the improved oral delivery of ziprasidone in vitro.
Meola TR; Dening TJ; Prestidge CA
Eur J Pharm Biopharm; 2018 Aug; 129():145-153. PubMed ID: 29857135
[TBL] [Abstract][Full Text] [Related]
14. Development of a solidified self-microemulsifying drug delivery system (S-SMEDDS) for atorvastatin calcium with improved dissolution and bioavailability.
Yeom DW; Son HY; Kim JH; Kim SR; Lee SG; Song SH; Chae BR; Choi YW
Int J Pharm; 2016 Jun; 506(1-2):302-11. PubMed ID: 27125455
[TBL] [Abstract][Full Text] [Related]
15. Lyophilized silica lipid hybrid (SLH) carriers for poorly water-soluble drugs: physicochemical and in vitro pharmaceutical investigations.
Yasmin R; Tan A; Bremmell KE; Prestidge CA
J Pharm Sci; 2014 Sep; 103(9):2950-2959. PubMed ID: 24585389
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.
Porter CJ; Kaukonen AM; Boyd BJ; Edwards GA; Charman WN
Pharm Res; 2004 Aug; 21(8):1405-12. PubMed ID: 15359575
[TBL] [Abstract][Full Text] [Related]
17. Tablets and minitablets prepared from spray-dried SMEDDS containing naproxen.
Čerpnjak K; Pobirk AZ; Vrečer F; Gašperlin M
Int J Pharm; 2015 Nov; 495(1):336-346. PubMed ID: 26341323
[TBL] [Abstract][Full Text] [Related]
18. Effects of spray-drying and choice of solid carriers on concentrations of Labrasol® and Transcutol® in solid self-microemulsifying drug delivery systems (SMEDDS).
Li L; Yi T; Lam CW
Molecules; 2013 Jan; 18(1):545-60. PubMed ID: 23282540
[TBL] [Abstract][Full Text] [Related]
19. Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib.
Tan A; Davey AK; Prestidge CA
Pharm Res; 2011 Sep; 28(9):2273-87. PubMed ID: 21560021
[TBL] [Abstract][Full Text] [Related]
20. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
Cirri M; Mura P; Mora PC
Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
